Cargando…
Development of Safe and Effective RSV Vaccine by Modified CD4 Epitope in G Protein Core Fragment (Gcf)
Respiratory syncytial virus (RSV) is a major cause of respiratory tract infection in infants and young children worldwide, but currently no safe and effective vaccine is available. The RSV G glycoprotein (RSVG), a major attachment protein, is an important target for the induction of protective immun...
Autores principales: | Cheon, In Su, Shim, Byoung-Shik, Park, Sung-Moo, Choi, Youngjoo, Jang, Ji Eun, Jung, Dae Im, Kim, Jae-Ouk, Chang, Jun, Yun, Cheol-Heui, Song, Man Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988050/ https://www.ncbi.nlm.nih.gov/pubmed/24736750 http://dx.doi.org/10.1371/journal.pone.0094269 |
Ejemplares similares
-
Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection
por: Cheon, In Su, et al.
Publicado: (2019) -
Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
por: Shim, Byoung-Shik, et al.
Publicado: (2018) -
Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity
por: Shim, Byoung-Shik, et al.
Publicado: (2013) -
Epitope-Specific Serological Assays for RSV: Conformation Matters
por: Phung, Emily, et al.
Publicado: (2019) -
Human Gingival Crevicular Fluids (GCF) Proteomics: An Overview
por: Khurshid, Zohaib, et al.
Publicado: (2017)